NCT02318407 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee Pain Status COMPLETED Phase PHASE1
NCT02315716 Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02307513 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease Status COMPLETED Phase PHASE3
NCT02304484 Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab Status COMPLETED Phase PHASE3
NCT02303821 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT02303522 Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase N/A
NCT02302495 Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma Status COMPLETED Phase PHASE2
NCT02301962 Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE4
NCT02297529 Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma Status NO_LONGER_AVAILABLE Phase N/A
NCT02294357 Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib Status TERMINATED Phase PHASE2
NCT02293109 Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma Status COMPLETED Phase PHASE1
NCT02291614 A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal Cancer Status TERMINATED Phase PHASE1
NCT02291588 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02289417 Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02287610 A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02279173 Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE3
NCT02275156 Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab Status COMPLETED Phase PHASE1
NCT02274792 Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT02269085 Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma Status TERMINATED Phase PHASE1